LILLY &lt;LLY> CUTS LIPOSOME CO &lt;LIPO> STAKE
  Eli Lilly and Co told the Securities
  and Exchange Commission it cut its stake in Liposome Co Inc to
  500,000 shares, or 4.0 pct of the total outstanding common
  stock, from 900,000 shares or 7.3 pct.
      Lilly said it sold 400,000 Liposome common shares on March
  17 at eight dlrs each.
      As long as Lilly's stake in Liposome is below five pct, it
  is not required to report any further dealings it has in the
  company's stock.
  

